We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a ...

Quest Partners LLC lowered its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 64.1% during the 3rd quarter ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third quarter ...

On Wednesday, DexCom Inc (DXCM) stock saw a modest uptick, ending the day at $78.1 which represents a slight increase of $0.16 or 0.21% from the prior close of $77.94. The stock opened at $78.43 and ...

Leerink Partners analyst Mike Kratky maintained a Buy rating on Dexcom (DXCM – Research Report) on November 25 and set a price target of ...

Investment analysts at Leerink Partnrs lifted their Q4 2024 earnings per share estimates for shares of DexCom in a note ...

DXCM is a #3 (Hold) on the Zacks Rank, with a VGM Score of B. Momentum investors should take note of this Medical stock. DXCM has a Momentum Style Score of A, and shares are up 8% over the past ...

Dexcom (DXCM) stock is down over 40% in Friday's session after the continuous glucose monitoring technology company fell short of revenue estimates for its second quarter and slashed its full-year ...

Let's consider two that specialize in developing medical devices: DexCom (NASDAQ: DXCM) and Intuitive Surgical (NASDAQ: ISRG). DexCom has encountered some issues lately. Key Insights The projected ...